Last updated: July 21, 2023
Sponsor: All India Institute of Medical Sciences, Bhubaneswar
Overall Status: Completed
Phase
2/3
Condition
Constipation
Bowel Dysfunction
Rectal Disorders
Treatment
Isabgol + Lactulose
Polyethylene Glycol
Clinical Study ID
NCT05341180
IEC/AIIMS BBSR/PG Thesis/
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- All patients presenting with acute fissure in ano between the age group of 18 to 75years.
Exclusion
Exclusion Criteria:
- Pregnancy / lactation
- Patients not giving consent
- Patients not able to understand the nature of the study
- Diabetes mellitus and chronic kidney disease
- Known intolerance to PEG/Lactulose or Isabgol
- Prior enrolment in other study.
- Patient undergoing surgery for Fissure in Ano
Study Design
Total Participants: 144
Treatment Group(s): 2
Primary Treatment: Isabgol + Lactulose
Phase: 2/3
Study Start date:
May 27, 2022
Estimated Completion Date:
July 22, 2023
Study Description
Connect with a study center
All India Institute of Medical Sciences
Bhubaneswar, Odisha 751019
IndiaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.